-
1
-
-
34548735210
-
Dynamic polyconjugates for targeted in vivo delivery of siRNA to hepatocytes
-
Rozema DB, Lewis DL, Wakefi eld DH, Wong SC, Klein JJ, Roesch PL, Bertin SL, Reppen TW, Chu Q, Blokhin AV et al (2007) Dynamic polyconjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc Natl Acad Sci U S A 104:12982–12987
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 12982-12987
-
-
Rozema, D.B.1
Lewis, D.L.2
Wakefi Eld, D.H.3
Wong, S.C.4
Klein, J.J.5
Roesch, P.L.6
Bertin, S.L.7
Reppen, T.W.8
Chu, Q.9
Blokhin, A.V.10
-
2
-
-
25444518193
-
Membrane activity and transfection ability of amphipathic polycations as a function of alkyl group size
-
Wakefi eld DH, Klein JJ, Wolff JA, Rozema DB (2005) Membrane activity and transfection ability of amphipathic polycations as a function of alkyl group size. Bioconjug Chem 16: 1204–1208
-
(2005)
Bioconjug Chem
, vol.16
, pp. 1204-1208
-
-
Wakefi Eld, D.H.1
Klein, J.J.2
Wolff, J.A.3
Rozema, D.B.4
-
3
-
-
0037257707
-
Endosomolysis by masking of a membrane-active agent (EMMA) for cytoplasmic release of macromolecules
-
Rozema DB, Ekena K, Lewis DL, Loomis AG, Wolff JA (2003) Endosomolysis by masking of a membrane-active agent (EMMA) for cytoplasmic release of macromolecules. Bioconjug Chem 14:51–57
-
(2003)
Bioconjug Chem
, vol.14
, pp. 51-57
-
-
Rozema, D.B.1
Ekena, K.2
Lewis, D.L.3
Loomis, A.G.4
Wolff, J.A.5
-
4
-
-
9144247189
-
Therapeutic silencing of an endogenous gene by systemic administration of modifi ed siRNAs
-
Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M, Elbashir S, Geick A, Hadwiger P, Harborth J et al (2004) Therapeutic silencing of an endogenous gene by systemic administration of modifi ed siRNAs. Nature 432:173–178
-
(2004)
Nature
, vol.432
, pp. 173-178
-
-
Soutschek, J.1
Akinc, A.2
Bramlage, B.3
Charisse, K.4
Constien, R.5
Donoghue, M.6
Elbashir, S.7
Geick, A.8
Hadwiger, P.9
Harborth, J.10
-
5
-
-
35148815670
-
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
-
Wolfrum C, Shi S, Jayaprakash KN, Jayaraman M, Wang G, Pandey RK, Rajeev KG, Nakayama T, Charrise K, Ndungo EM et al (2007) Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nat Biotechnol 25:1149–1157
-
(2007)
Nat Biotechnol
, vol.25
, pp. 1149-1157
-
-
Wolfrum, C.1
Shi, S.2
Jayaprakash, K.N.3
Jayaraman, M.4
Wang, G.5
Pandey, R.K.6
Rajeev, K.G.7
Nakayama, T.8
Charrise, K.9
Ndungo, E.M.10
-
6
-
-
84870570270
-
Co-injection of a targeted, reversibly masked endosomolytic polymer dramatically improves the effi cacy of cholesterol-conjugated small interfering RNAs in vivo
-
Wong SC, Klein JJ, Hamilton HL, Chu Q, Frey CL, Trubetskoy VS, Hegge J, Wakefi eld D, Rozema DB, Lewis DL (2012) Co-injection of a targeted, reversibly masked endosomolytic polymer dramatically improves the effi cacy of cholesterol-conjugated small interfering RNAs in vivo. Nucleic Acid Ther 22:380–390
-
(2012)
Nucleic Acid Ther
, vol.22
, pp. 380-390
-
-
Wong, S.C.1
Klein, J.J.2
Hamilton, H.L.3
Chu, Q.4
Frey, C.L.5
Trubetskoy, V.S.6
Hegge, J.7
Wakefi Eld, D.8
Rozema, D.B.9
Lewis, D.L.10
-
7
-
-
84877026189
-
Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection
-
Wooddell CI, Rozema DB, Hossbach M, John M, Hamilton HL, Chu Q, Hegge JO, Klein JJ, Wakefi eld DH, Oropeza CE et al (2013) Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection. Mol Ther J Am Soc Gene Ther 21:973–985
-
(2013)
Mol Ther J Am Soc Gene Ther
, vol.21
, pp. 973-985
-
-
Wooddell, C.I.1
Rozema, D.B.2
Hossbach, M.3
John, M.4
Hamilton, H.L.5
Chu, Q.6
Hegge, J.O.7
Klein, J.J.8
Wakefi Eld, D.H.9
Oropeza, C.E.10
-
9
-
-
79956077563
-
T cell exhaustion
-
Wherry EJ (2011) T cell exhaustion. Nat Immunol 12:492–499
-
(2011)
Nat Immunol
, vol.12
, pp. 492-499
-
-
Wherry, E.J.1
-
10
-
-
65449117946
-
Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAgnegative chronic hepatitis B
-
Brunetto MR, Moriconi F, Bonino F, Lau GK, Farci P, Yurdaydin C, Piratvisuth T, Luo K, Wang Y, Hadziyannis S et al (2009) Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAgnegative chronic hepatitis B. Hepatology 49:1141–1150
-
(2009)
Hepatology
, vol.49
, pp. 1141-1150
-
-
Brunetto, M.R.1
Moriconi, F.2
Bonino, F.3
Lau, G.K.4
Farci, P.5
Yurdaydin, C.6
Piratvisuth, T.7
Luo, K.8
Wang, Y.9
Hadziyannis, S.10
-
11
-
-
78650477355
-
Three-year effi - cacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B
-
Heathcote EJ, Marcellin P, Buti M, Gane E, De Man RA, Krastev Z, Germanidis G, Lee SS, Flisiak R, Kaita K et al (2011) Three-year effi - cacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B. Gastroenterology 140:132–143
-
(2011)
Gastroenterology
, vol.140
, pp. 132-143
-
-
Heathcote, E.J.1
Marcellin, P.2
Buti, M.3
Gane, E.4
De Man, R.A.5
Krastev, Z.6
Germanidis, G.7
Lee, S.S.8
Flisiak, R.9
Kaita, K.10
-
12
-
-
67349168493
-
High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up study
-
Moucari R, Korevaar A, Lada O, Martinot- Peignoux M, Boyer N, Mackiewicz V, Dauvergne A, Cardoso AC, Asselah T, Nicolas- Chanoine MH et al (2009) High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study. J Hepatol 50:1084–1092
-
(2009)
J Hepatol
, vol.50
, pp. 1084-1092
-
-
Moucari, R.1
Korevaar, A.2
Lada, O.3
Martinot- Peignoux, M.4
Boyer, N.5
Mackiewicz, V.6
Dauvergne, A.7
Cardoso, A.C.8
Asselah, T.9
Nicolas- Chanoine, M.H.10
-
13
-
-
65449123444
-
Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAgnegative patients
-
Moucari R, Mackiewicz V, Lada O, Ripault MP, Castelnau C, Martinot-Peignoux M, Dauvergne A, Asselah T, Boyer N, Bedossa P et al (2009) Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAgnegative patients. Hepatology 49:1151–1157
-
(2009)
Hepatology
, vol.49
, pp. 1151-1157
-
-
Moucari, R.1
Mackiewicz, V.2
Lada, O.3
Ripault, M.P.4
Castelnau, C.5
Martinot-peignoux, M.6
Dauvergne, A.7
Asselah, T.8
Boyer, N.9
Bedossa, P.10
-
14
-
-
72949113706
-
Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naive HBeAg-positive patients with chronic hepatitis B
-
Gish RG, Chang TT, Lai CL, de Man R, Gadano A, Poordad F, Yang J, Brett-Smith H, Tamez R (2010) Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naive HBeAg-positive patients with chronic hepatitis B. J Viral Hepat 17:16–22
-
(2010)
J Viral Hepat
, vol.17
, pp. 16-22
-
-
Gish, R.G.1
Chang, T.T.2
Lai, C.L.3
De Man, R.4
Gadano, A.5
Poordad, F.6
Yang, J.7
Brett-smith, H.8
Tamez, R.9
-
15
-
-
33745614074
-
Positionspecifi c chemical modifi cation of siRNAs reduces “off- target” transcript silencing
-
Jackson AL, Burchard J, Leake D, Reynolds A, Schelter J, Guo J, Johnson JM, Lim L, Karpilow J, Nichols K et al (2006) Positionspecifi c chemical modifi cation of siRNAs reduces “off- target” transcript silencing. RNA 12:1197–1205
-
(2006)
RNA
, vol.12
, pp. 1197-1205
-
-
Jackson, A.L.1
Burchard, J.2
Leake, D.3
Reynolds, A.4
Schelter, J.5
Guo, J.6
Johnson, J.M.7
Lim, L.8
Karpilow, J.9
Nichols, K.10
-
16
-
-
23444445660
-
Potent and persistent in vivo anti-HBV activity of chemically modifi ed siRNAs
-
Morrissey DV, Lockridge JA, Shaw L, Blanchard K, Jensen K, Breen W, Hartsough K, Machemer L, Radka S, Jadhav V et al (2005) Potent and persistent in vivo anti-HBV activity of chemically modifi ed siRNAs. Nat Biotechnol 23:1002–1007
-
(2005)
Nat Biotechnol
, vol.23
, pp. 1002-1007
-
-
Morrissey, D.V.1
Lockridge, J.A.2
Shaw, L.3
Blanchard, K.4
Jensen, K.5
Breen, W.6
Hartsough, K.7
Machemer, L.8
Radka, S.9
Jadhav, V.10
-
17
-
-
34547134721
-
Suppression of immunostimulatory siRNAdriven innate immune activation by 2′-modifi ed RNAs
-
Sioud M, Furset G, Cekaite L (2007) Suppression of immunostimulatory siRNAdriven innate immune activation by 2′-modifi ed RNAs. Biochem Biophys Res Commun 361:122–126
-
(2007)
Biochem Biophys Res Commun
, vol.361
, pp. 122-126
-
-
Sioud, M.1
Furset, G.2
Cekaite, L.3
-
18
-
-
0029130068
-
High-level hepatitis B virus replication in transgenic mice
-
Guidotti LG, Matzke B, Schaller H, Chisari FV (1995) High-level hepatitis B virus replication in transgenic mice. J Virol 69:6158–6169
-
(1995)
J Virol
, vol.69
, pp. 6158-6169
-
-
Guidotti, L.G.1
Matzke, B.2
Schaller, H.3
Chisari, F.V.4
-
19
-
-
0037108818
-
Hydrodynamic injection of viral DNA: A mouse model of acute hepatitis B virus infection
-
Yang PL, Althage A, Chung J, Chisari FV (2002) Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci U S A 99:13825–13830
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 13825-13830
-
-
Yang, P.L.1
Althage, A.2
Chung, J.3
Chisari, F.V.4
-
20
-
-
0033166561
-
High levels of foreign gene expression in hepatocytes after tail vein injection of naked plasmid DNA
-
Zhang G, Budker V, Wolff JA (1999) High levels of foreign gene expression in hepatocytes after tail vein injection of naked plasmid DNA. Hum Gene Ther 10:1735–1737
-
(1999)
Hum Gene Ther
, vol.10
, pp. 1735-1737
-
-
Zhang, G.1
Budker, V.2
Wolff, J.A.3
-
21
-
-
84885533678
-
Minicircle DNA electrotransfer for effi cient tissue-targeted gene delivery
-
Chabot S, Orio J, Schmeer M, Schleef M, Golzio M, Teissie J (2012) Minicircle DNA electrotransfer for effi cient tissue-targeted gene delivery. Gene Ther 23(1):128–137
-
(2012)
Gene Ther
, vol.23
, Issue.1
, pp. 128-137
-
-
Chabot, S.1
Orio, J.2
Schmeer, M.3
Schleef, M.4
Golzio, M.5
Teissie, J.6
-
22
-
-
22144473690
-
Long-term RNA interference from optimized siRNA expression constructs in adult mice
-
Wooddell CI, Van Hout CV, Reppen T, Lewis DL, Herweijer H (2005) Long-term RNA interference from optimized siRNA expression constructs in adult mice. Biochem Biophys Res Commun 334:117–127
-
(2005)
Biochem Biophys Res Commun
, vol.334
, pp. 117-127
-
-
Wooddell, C.I.1
Van Hout, C.V.2
Reppen, T.3
Lewis, D.L.4
Herweijer, H.5
-
23
-
-
44449145951
-
Sustained liver-specifi c transgene expression from the albumin promoter in mice following hydrodynamic plasmid DNA delivery
-
Wooddell CI, Reppen T, Wolff JA, Herweijer H (2008) Sustained liver-specifi c transgene expression from the albumin promoter in mice following hydrodynamic plasmid DNA delivery. J Gene Med 10:551–563
-
(2008)
J Gene Med
, vol.10
, pp. 551-563
-
-
Wooddell, C.I.1
Reppen, T.2
Wolff, J.A.3
Herweijer, H.4
-
24
-
-
38049161918
-
RNAi for treating hepatitis B viral infection
-
Chen Y, Cheng G, Mahato RI (2008) RNAi for treating hepatitis B viral infection. Pharm Res 25:72–86
-
(2008)
Pharm Res
, vol.25
, pp. 72-86
-
-
Chen, Y.1
Cheng, G.2
Mahato, R.I.3
|